Dissecting the expression of EEF1A1/2 genes in human prostate cancer cells: the potential of EEF1A2 as a hallmark for prostate transformation and progression
Open Access
- 17 November 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 106 (1), 166-173
- https://doi.org/10.1038/bjc.2011.500
Abstract
In prostate adenocarcinoma, the dissection of the expression behaviour of the eukaryotic elongation factors (eEF1A1/2) has not yet fully elucidated. The EEF1A1/A2 expressions were investigated by real-time PCR, western blotting (cytoplasmic and cytoskeletal/nuclear-enriched fractions) and immunofluorescence in the androgen-responsive LNCaP and the non-responsive DU-145 and PC-3 cells, displaying a low, moderate and high aggressive phenotype, respectively. Targeted experiments were also conducted in the androgen-responsive 22Rv1, a cell line marking the progression towards androgen-refractory tumour. The non-tumourigenic prostate PZHPV-7 cell line was the control. Compared with PZHPV-7, cancer cells showed no major variations in EEF1A1 mRNA; eEF1A1 protein increased only in cytoskeletal/nuclear fraction. On the contrary, a significant rise of EEF1A2 mRNA and protein were found, with the highest levels detected in LNCaP. Eukaryotic elongation factor 1A2 immunostaining confirmed the western blotting results. Pilot evaluation in archive prostate tissues showed the presence of EEF1A2 mRNA in near all neoplastic and perineoplastic but not in normal samples or in benign adenoma; in contrast, EEF1A1 mRNA was everywhere detectable. Eukaryotic elongation factor 1A2 switch-on, observed in cultured tumour prostate cells and in human prostate tumour samples, may represent a feature of prostate cancer; in contrast, a minor involvement is assigned to EEF1A1. These observations suggest to consider EEF1A2 as a marker for prostate cell transformation and/or possibly as a hallmark of cancer progression.Keywords
This publication has 31 references indexed in Scilit:
- eEF1A2 as a Putative OncogeneAnnals of the New York Academy of Sciences, 2009
- Polybromo-1: The chromatin targeting subunit of the PBAF complexBiochimie, 2009
- Regulation and functional role of eEF1A2 in pancreatic carcinomaBiochemical and Biophysical Research Communications, 2009
- A2 isoform of mammalian translation factor eEF1A displays increased tyrosine phosphorylation and ability to interact with different signalling moleculesThe International Journal of Biochemistry & Cell Biology, 2008
- E2F1 Inhibits c-Myc-Driven Apoptosis via PIK3CA/Akt/mTOR and COX-2 in a Mouse Model of Human Liver CancerGastroenterology, 2008
- Tumor Necrosis Factor-α Downregulates Endothelial Nitric Oxide Synthase mRNA Stability via Translation Elongation Factor 1-α 1Circulation Research, 2008
- BPOZ‐2 directly binds to eEF1A1 to promote eEF1A1 ubiquitylation and degradation and prevent translationGenes to Cells, 2008
- Impact of differential cyclin D1 expression and localisation in prostate cancerBritish Journal of Cancer, 2007
- Expression of protein elongation factor eEF1A2 predicts favorable outcome in breast cancerBreast Cancer Research and Treatment, 2006
- Synchronized prostate cancer cells for studying androgen regulated events in cell cycle progression from G1 into S phaseJournal of Cellular Physiology, 2003